Martin Driscoll

2020

In 2020, Martin Driscoll earned a total compensation of $687.7K as Former Chief Executive Officer at F-star Therapeutics, a 52% decrease compared to previous year.

Compensation breakdown

Bonus$123,750
Salary$403,071
Stock Awards$56,400
Other$104,508
Total$687,729

Driscoll received $403.1K in salary, accounting for 59% of the total pay in 2020.

Driscoll also received $123.8K in bonus, $56.4K in stock awards and $104.5K in other compensation.

Rankings

In 2020, Martin Driscoll's compensation ranked 10,024th out of 13,090 executives tracked by ExecPay. In other words, Driscoll earned more than 23.4% of executives.

ClassificationRankingPercentile
All
10,024
out of 13,090
23rd
Division
Manufacturing
4,312
out of 5,618
23rd
Major group
Chemicals And Allied Products
1,773
out of 2,251
21st
Industry group
Drugs
1,551
out of 1,951
21st
Industry
Pharmaceutical Preparations
1,143
out of 1,456
22nd
Source: SEC filing on April 7, 2021.

Driscoll's colleagues

We found seven more compensation records of executives who worked with Martin Driscoll at F-star Therapeutics in 2020.

2020

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2020

Neil Brewis

F-star Therapeutics

Chief Scientific Officer

2020

Neil DSc

F-star Therapeutics

Chief Scientific Officer

2020

Louis Kayitalire

F-star Therapeutics

Chief Medical Officer

2020

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2020

RP Iyer

F-star Therapeutics

Chief Scientific Officer

2020

Jonathan Freve

F-star Therapeutics

Chief Financial Officer

News

You may also like